Skip to content

GoodRx Holdings, Inc.

GDRX · XNAS

CIK 1809519fmd_0S67H2CHCGTPSR3HRMB3R9E4YHServices · Services-Computer Processing & Data PreparationTemplate: Standard

Coverage: Jan 01, 2018 to Jun 30, 2026, 31 periods

Income Statement · Annual · Millions · USD
Line itemFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues250388551745767750792797
Research and development442962126143136124121
Selling, general and administrative113192717525502467485446
Operating income77140(276)132(27)6687
Interest expense2250282434575343
Other non-operating income (expense)(25)(57)(28)(24)(25)(29)(34)(31)
Income before taxes5283(303)(10)(23)(56)3157
Income tax expense917(10)1510(47)1526
Net income from continuing operations4466(294)(25)(33)(9)1630
Net income4466(294)(25)(33)(9)1630
Net income to common shareholders1442(294)(25)––––
GoodRx Holdings, Inc. (GDRX) financial statements · FinancialMD